PATENT CLAIM ANALYSIS

Application Number: 16086717
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "489000"]

Abstract:
The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.

Claim (Index 12):
The lyophilized pharmaceutical composition of  claim 4 , wherein the poly(lactic) acid portion of the poly(lactic) acid-block-poly(ethylene)glycol copolymer has a weight average molecular weight of about 16 kDa and the poly(ethylene)glycol portion of the poly(lactic) acid-block-poly(ethylene)glycol copolymer has a weight average molecular weight of about 5 kDa.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.14286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13664133', '15296350', '13916133', '13862090', '13909670']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8167514945787335
- 35 USC 102 Novelty (BERT): 0.5761022934406764
- Combined Prediction Score: 0.7926865744649279
- Mean Citation Score: 488.226772
- Max Citation Score: 495.44614
- Similarity Product: 401.5308481644857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test